216 related articles for article (PubMed ID: 24643931)
21. Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells.
Sánchez-Moreno P; Boulaiz H; Ortega-Vinuesa JL; Peula-García JM; Aránega A
Int J Mol Sci; 2012; 13(4):4906-4919. PubMed ID: 22606019
[TBL] [Abstract][Full Text] [Related]
22. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.
Castro A; Berois N; Malanga A; Ortega C; Oppezzo P; Pristch O; Mombrú AW; Osinaga E; Pardo H
Int J Biol Macromol; 2021 Jul; 182():806-814. PubMed ID: 33857513
[TBL] [Abstract][Full Text] [Related]
24. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.
Maiolino S; Moret F; Conte C; Fraix A; Tirino P; Ungaro F; Sortino S; Reddi E; Quaglia F
Nanoscale; 2015 Mar; 7(13):5643-53. PubMed ID: 25648974
[TBL] [Abstract][Full Text] [Related]
26. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
[TBL] [Abstract][Full Text] [Related]
27. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
28. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
[TBL] [Abstract][Full Text] [Related]
29. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
30. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
[TBL] [Abstract][Full Text] [Related]
31. Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer.
Haggag YA; Ibrahim RR; Hafiz AA
Int J Nanomedicine; 2020; 15():1625-1642. PubMed ID: 32210557
[TBL] [Abstract][Full Text] [Related]
32. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
34. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
Liu Q; Li RT; Qian HQ; Yang M; Zhu ZS; Wu W; Qian XP; Yu LX; Jiang XQ; Liu BR
Int J Nanomedicine; 2012; 7():281-95. PubMed ID: 22287839
[TBL] [Abstract][Full Text] [Related]
35. Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment.
Ma Y; Zheng Y; Zeng X; Jiang L; Chen H; Liu R; Huang L; Mei L
Int J Nanomedicine; 2011; 6():2679-88. PubMed ID: 22114498
[TBL] [Abstract][Full Text] [Related]
36. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
Choi JS; Park JS
Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
[TBL] [Abstract][Full Text] [Related]
37. Preparation of Engineered Salmonella Typhimurium-Driven Hyaluronic-Acid-Based Microbeads with Both Chemotactic and Biological Targeting Towards Breast Cancer Cells for Enhanced Anticancer Therapy.
Uthaman S; Zheng S; Han J; Choi YJ; Cho S; Nguyen VD; Park JO; Park SH; Min JJ; Park S; Park IK
Adv Healthc Mater; 2016 Jan; 5(2):288-95. PubMed ID: 26584018
[TBL] [Abstract][Full Text] [Related]
38. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
39. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
[TBL] [Abstract][Full Text] [Related]
40. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
